Photo of Keara Redmond

Keara Redmond

Dr

  • Room 03.006 - CCRCB

    United Kingdom

20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Keara Redmond is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 36 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 7 Article
  • 4 Conference contribution

Fibroblast-derived Gremlin1 localises to epithelial cells at the base of the intestinal crypt

Dutton, L. R., Hoare, O. P., McCorry, A. M. B., Redmond, K. L., Adam, N. E., Canamara, S., Bingham, V., Mullan, P. B., Lawler, M., Dunne, P. D. & Brazil, D. P., 23 Jul 2019, In : Oncotarget. 10, 45, p. 4630-4639 10 p.

Research output: Contribution to journal › Article

Open Access
File
    • 1 Citation (Scopus)
    97 Downloads (Pure)

    EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer

    Dunne, P. D., Dasgupta, S., Blayney, J. K., McArt, D. G., Redmond, K. L., Weir, J-A., Bradley, C. A., Sasazuki, T., Shirasawa, S., Wang, T., Srivastava, S., Ong, C. W., Arthur, K., Salto-Tellez, M., Wilson, R. H., Johnston, P. G. & Van Schaeybroeck, S., 01 Jan 2016, In : Clinical Cancer Research. 22, 1, p. 230-242 13 p.

    Research output: Contribution to journal › Article

    • 51 Citations (Scopus)

    Overcoming Resistance to Targeted Therapies in Cancer

    Redmond, K. L., Papafili, A., Lawler, M. & Van Schaeybroeck, S., Dec 2015, In : Seminars in Oncology. 42, 6, p. 896-908 13 p.

    Research output: Contribution to journal › Article

    • 28 Citations (Scopus)

    The role of micro-environment-derived ligands in resistance to EGFR monoclonal antibodies in KRAS wild type colorectal cancer

    Weir, J-A., Redmond, K., Bradley, C. & Van Schaeybroeck, S., Nov 2015, The role of micro-environment-derived ligands in resistance to EGFR monoclonal antibodies in KRAS wild type colorectal cancer. National Cancer Research Institute, Vol. A87.

    Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

    ADAM17-Dependent c-MET-STAT3 Signaling Mediates Resistance to MEK Inhibitors in KRAS Mutant Colorectal Cancer

    Van Schaeybroeck, S., Kalimutho, M., Dunne, P. D., Carson, R., Allen, W., Jithesh, P. V., Redmond, K. L., Sasazuki, T., Shirasawa, S., Blayney, J., Michieli, P., Fenning, C., Lenz, H-J., Lawler, M., Longley, D. B. & Johnston, P. G., 26 Jun 2014, In : Cell Reports. 7, 6, p. 1940-1955 16 p.

    Research output: Contribution to journal › Article

    Open Access
    File
    • 48 Citations (Scopus)
    307 Downloads (Pure)